Epinephrine Patent Expiration
Epinephrine was first introduced by Sterling Health Div Sterling Winthrop Inc
Epinephrine Patents
Given below is the list of patents protecting Epinephrine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Epinephrine | US12539283 | Jan 17, 2045 | Fresenius Kabi Usa | |
| Adrenalin | US10653646 | Epinephrine compositions and containers | Mar 21, 2039 | Ph Health |
| Adrenalin | US11083698 | Epinephrine compositions and containers | Mar 21, 2039 | Ph Health |
| Adrenalin | US11207280 | Epinephrine compositions and containers | Mar 21, 2039 | Ph Health |
| Adrenalin | US12133837 | Epinephrine compositions and containers | Mar 21, 2039 | Ph Health |
| Neffy | US10682414 | Intranasal epinephrine formulations and methods for the treatment of disease | Feb 06, 2039 | Ars Pharms Operation |
| Neffy | US11191838 | Intranasal epinephrine formulations and methods for the treatment of disease | Feb 06, 2039 | Ars Pharms Operation |
| Neffy | US11717571 | Intranasal epinephrine formulations and methods for the treatment of disease | Feb 06, 2039 | Ars Pharms Operation |
| Neffy | US11744895 | Intranasal epinephrine formulations and methods for the treatment of disease | Feb 06, 2039 | Ars Pharms Operation |
| Neffy | US11918655 | Intranasal epinephrine formulations and methods for the treatment of disease | Feb 06, 2039 | Ars Pharms Operation |
| Neffy | US12324838 | Intranasal epinephrine formulations and methods for the treatment of disease | Feb 06, 2039 | Ars Pharms Operation |
| Neffy | US10576156 | Compositions for drug administration | Feb 06, 2038 | Ars Pharms Operation |
| Neffy | US11173209 | Compositions for drug administration | Feb 06, 2038 | Ars Pharms Operation |
| Auvi-q | US10688244 | Medicament delivery device and methods for delivering drugs to infants and children | Dec 21, 2037 | Kaleo Inc |
| Auvi-q | US10842938 | Medicament delivery device and methods for delivering drugs to infants and children | Dec 21, 2037 | Kaleo Inc |
| Auvi-q | US11771830 | Medicament delivery device and methods for delivering drugs to infants and children | Dec 21, 2037 | Kaleo Inc |
| Symjepi | US11141540 | Syringe devices | Oct 20, 2036 | Adamis Pharms Corp |
| Adrenalin | US10130592 | Epinephrine formulations | Mar 13, 2035 | Ph Health |
| Adrenalin | US12280024 | Epinephrine formulations | Mar 13, 2035 | Ph Health |
| Adrenalin | US9119876 | Epinephrine formulations | Mar 13, 2035 | Ph Health |
| Adrenalin | US9295657 | Epinephrine formulations | Mar 13, 2035 | Ph Health |
| Epinephrine | US9283197 | More potent and less toxic formulations of epinephrine and methods of medical use | Aug 15, 2034 | Bpi Labs |
| Epinephrine | US10004700 | More potent and less toxic formulations of epinephrine and methods of medical use | Aug 14, 2034 | Bpi Labs |
| Epinephrine | US10039728 | More potent and less toxic formulations of epinephrine and methods of medical use | Aug 14, 2034 | Bpi Labs |
| Auvi-q | US8021344 | Medicament delivery device configured to produce an audible output | Nov 02, 2029 | Kaleo Inc |
| Auvi-q | US8226610 | Medical injector with compliance tracking and monitoring | Apr 10, 2029 | Kaleo Inc |
| Auvi-q | US8231573 | Medicament delivery device having an electronic circuit system | Nov 25, 2028 | Kaleo Inc |
| Auvi-q | US7749194 | Devices, systems, and methods for medicament delivery | Oct 30, 2028 | Kaleo Inc |
| Auvi-q | US7947017 | Devices, systems and methods for medicament delivery | Mar 12, 2028 | Kaleo Inc |
| Auvi-q | US9724471 | Devices, systems, and methods for medicament delivery | May 23, 2027 | Kaleo Inc |
| Adrenaclick | US7905352 | Kits containing medicine injection devices and containers | Apr 12, 2027 | Impax |
| Auvi-q | US8206360 | Devices, systems and methods for medicament delivery | Feb 27, 2027 | Kaleo Inc |
| Auvi-q | US9238108 | Medicament delivery device having an electronic circuit system | Feb 20, 2027 | Kaleo Inc |
| Auvi-q | US11590286 | Devices, systems and methods for medicament delivery | Dec 12, 2026 | Kaleo Inc |
| Auvi-q | US10960155 | Devices, systems and methods for medicament delivery |
Jun 25, 2026
(Expired) | Kaleo Inc |
| Auvi-q | US7731686 | Devices, systems and methods for medicament delivery |
Jun 01, 2026
(Expired) | Kaleo Inc |
| Auvi-q | US8926594 | Devices, systems and methods for medicament delivery |
Mar 31, 2026
(Expired) | Kaleo Inc |
| Auvi-q | US9259539 | Devices, systems and methods for medicament delivery |
Feb 01, 2026
(Expired) | Kaleo Inc |
| Auvi-q | US9278182 | Devices, systems and methods for medicament delivery |
Feb 01, 2026
(Expired) | Kaleo Inc |
| Primatene Mist | US8367734 | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
Jan 26, 2026
(Expired) | Armstrong Pharms |
| Epipen | US7449012 | Automatic injector |
Sep 11, 2025
(Expired) | Viatris |
| Epipen | US7794432 | Automatic injector with kickback attenuation |
Sep 11, 2025
(Expired) | Viatris |
| Epipen | US8048035 | Automatic injector with needle cover |
Sep 11, 2025
(Expired) | Viatris |
| Epipen | US8870827 | Automatic injector |
Sep 11, 2025
(Expired) | Viatris |
| Epipen | US9586010 | Automatic injector with needle cover |
Sep 11, 2025
(Expired) | Viatris |
| Epipen Jr. | US7449012 | Automatic injector |
Sep 11, 2025
(Expired) | Viatris |
| Epipen Jr. | US7794432 | Automatic injector with kickback attenuation |
Sep 11, 2025
(Expired) | Viatris |
| Epipen Jr. | US8048035 | Automatic injector with needle cover |
Sep 11, 2025
(Expired) | Viatris |
| Epipen Jr. | US8870827 | Automatic injector |
Sep 11, 2025
(Expired) | Viatris |
| Epipen Jr. | US9586010 | Automatic injector with needle cover |
Sep 11, 2025
(Expired) | Viatris |
| Auvi-q | US9149579 | Devices, systems and methods for medicament delivery |
Jul 19, 2025
(Expired) | Kaleo Inc |
| Auvi-q | US10335549 | Devices, systems and methods for medicament delivery |
Apr 30, 2025
(Expired) | Kaleo Inc |
| Auvi-q | US8016788 | Devices, systems and methods for medicament delivery |
Mar 21, 2025
(Expired) | Kaleo Inc |
| Twinject | US7621891 | Method and apparatus for delivering epinephrine |
Feb 04, 2025
(Expired) | Impax |
| Adrenaclick | US10166334 | Medicine injection apparatuses |
Jan 21, 2025
(Expired) | Impax |
| Adrenaclick | US10166344 | Injection needle assembly |
Jan 21, 2025
(Expired) | Impax |
| Twinject | US7297136 | Medicine injection devices and methods |
Jan 18, 2025
(Expired) | Impax |
| Auvi-q | US7731690 | Devices, systems and methods for medicament delivery |
Jan 15, 2025
(Expired) | Kaleo Inc |
| Auvi-q | US10314977 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US10737028 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US7918823 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US8313466 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US8361029 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US8425462 | Devices, systems, and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US8608698 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US8920377 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US9056170 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US9737669 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Auvi-q | US9833573 | Devices, systems and methods for medicament delivery |
Nov 23, 2024
(Expired) | Kaleo Inc |
| Adrenaclick | US5665071 | Reloadable automatic or manual emergency injection system |
May 27, 2013
(Expired) | Impax |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Epinephrine's patents.
Latest Legal Activities on Epinephrine's Patents
Given below is the list recent legal activities going on the following patents of Epinephrine.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 10 Feb, 2026 | US12539283 |
| Mail Patent eGrant Notification | 03 Feb, 2026 | US12539283 |
| Email Notification | 03 Feb, 2026 | US12539283 |
| Recordation of Patent eGrant | 03 Feb, 2026 | US12539283 |
| Patent Issue Date Used in PTA Calculation | 03 Feb, 2026 | US12539283 |
| Patent eGrant Notification | 03 Feb, 2026 | US12539283 |
| Email Notification | 22 Jan, 2026 | US12539283 |
| Issue Notification Mailed | 21 Jan, 2026 | US12539283 |
| Dispatch to FDC | 12 Jan, 2026 | US12539283 |
| Email Notification | 07 Jan, 2026 | US12539283 |
Epinephrine's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Epinephrine:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
